首页 > 最新文献

Journal of the Medical Association of Thailand = Chotmaihet thangphaet最新文献

英文 中文
Experience of Tacrolimus Usage in Kidney Transplant Vietnamese Patients 他克莫司在越南肾移植患者中的应用体会
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13878
Background: Tacrolimus (Tac) has been widely used with other immunosuppressive agents to prevent graft rejection post-kidney transplantation. However, the usage of Tac has depended on experience rather than evidence-based methods. In the present study, the authors investigated the Tac usage patterns and outcomes in kidney-transplanted patients at a transplant center located in the North of Vietnam.Materials and Methods: A retrospective cross-sectional study was conducted. Patients were included if they underwent renal transplantation, received Tac as part of the immunosuppressive therapy, and had been followed up in Viet Duc Hospital during the period between February 2009 and February 2019. Excluded patients were those who did not use Tac or switched to another drug during treatment.Results: The number of followed up patients steadily decreased from 342 cases in the first six months to 281 cases in the second year, 217 in the third year, 185 in the fourth year, and 152 in the fifth year post-transplanted. Only 17 cases had a ten-year follow-up. The number of transplants from deceased donors at 9.6% was much lower than live donors at 90.4%. Three patients died through the five years of the follow-up due to causes unrelated to kidney transplantation. Ten cases were ABO-incompatible transplantations. The mean blood concentration of Tac was highest in the first six months with 10.6 ng/mL, then gradually dropped to the lowest value at 6.3 ng/mL in the fifth year. Seven cases were identified as graft rejection with no clear outcome.Conclusion: Although there were a lack of standard tests and facilities for taking care of kidney transplant patients, the intra-patient variability and Tac concentration of included patients in the author’s center were close to the international studies in developed countries in five years follow-up.Keywords: Tacrolimus; Transplantation; Kidney; Vietnam
背景:他克莫司(Tac)已与其他免疫抑制剂广泛应用于预防肾移植后的移植排斥反应。然而,Tac的使用依赖于经验,而不是基于证据的方法。在本研究中,作者调查了位于越南北部的移植中心肾移植患者的Tac使用模式和结果。材料与方法:回顾性横断面研究。如果患者接受了肾移植,作为免疫抑制治疗的一部分接受了Tac治疗,并在2009年2月至2019年2月期间在Viet Duc医院进行了随访,则纳入患者。排除的患者是那些在治疗期间未使用Tac或改用其他药物的患者。结果:移植后随访患者数量稳步下降,从前6个月的342例下降到第二年的281例,第三年217例,第四年185例,第五年152例。只有17例进行了10年的随访。已故捐献者的移植比例为9.6%,远低于活体捐献者的90.4%。在5年的随访中,有3名患者死于与肾移植无关的原因。10例为abo血型不相容移植。Tac平均血药浓度在前6个月最高,为10.6 ng/mL,第5年逐渐降至最低,为6.3 ng/mL。7例被确定为移植物排斥,没有明确的结果。结论:虽然缺乏标准的肾移植患者护理测试和设施,但作者中心纳入患者的患者内部变异性和Tac浓度在5年随访中接近发达国家的国际研究。关键词:他克莫司;移植;肾脏;越南
{"title":"Experience of Tacrolimus Usage in Kidney Transplant Vietnamese Patients","authors":"","doi":"10.35755/jmedassocthai.2023.08.13878","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13878","url":null,"abstract":"Background: Tacrolimus (Tac) has been widely used with other immunosuppressive agents to prevent graft rejection post-kidney transplantation. However, the usage of Tac has depended on experience rather than evidence-based methods. In the present study, the authors investigated the Tac usage patterns and outcomes in kidney-transplanted patients at a transplant center located in the North of Vietnam.\u0000\u0000Materials and Methods: A retrospective cross-sectional study was conducted. Patients were included if they underwent renal transplantation, received Tac as part of the immunosuppressive therapy, and had been followed up in Viet Duc Hospital during the period between February 2009 and February 2019. Excluded patients were those who did not use Tac or switched to another drug during treatment.\u0000\u0000Results: The number of followed up patients steadily decreased from 342 cases in the first six months to 281 cases in the second year, 217 in the third year, 185 in the fourth year, and 152 in the fifth year post-transplanted. Only 17 cases had a ten-year follow-up. The number of transplants from deceased donors at 9.6% was much lower than live donors at 90.4%. Three patients died through the five years of the follow-up due to causes unrelated to kidney transplantation. Ten cases were ABO-incompatible transplantations. The mean blood concentration of Tac was highest in the first six months with 10.6 ng/mL, then gradually dropped to the lowest value at 6.3 ng/mL in the fifth year. Seven cases were identified as graft rejection with no clear outcome.\u0000\u0000Conclusion: Although there were a lack of standard tests and facilities for taking care of kidney transplant patients, the intra-patient variability and Tac concentration of included patients in the author’s center were close to the international studies in developed countries in five years follow-up.\u0000\u0000Keywords: Tacrolimus; Transplantation; Kidney; Vietnam","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87484183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Levetiracetam versus Phenytoin in Neonatal Seizure in Rural Area of Thailand 左乙拉西坦与苯妥英在泰国农村新生儿癫痫发作中的疗效比较
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13877
Background: Neonatal seizure is an emergency condition that affects neurodevelopment and mortality. The appropriate treatment and seizure termination is crucial. Previous studies determined the efficacy of different types of antiseizure medications (ASMs), but there is no consensus toward second-line ASMs in neonatal seizure.Objective: To compare the efficacy of second-line ASMs in neonatal seizure, compared between levetiracetam and phenytoin.Materials and Methods: The present study was a retrospective study. The author recruited patients with diagnosis of neonatal seizure admitted at Maharat Nakhon Ratchasima Hospital, Thailand, between January 1, 2018 and December 31, 2020. Patients who had clinical seizure refractory and were given first-line ASM (intravenous phenobarbital) and received second-line ASMs as intravenous levetiracetam or intravenous phenytoin were included. Etiologies of seizure, seizure types, and other demographic data were recorded. The efficacy of levetiracetam and phenytoin were determined by comparing the duration of seizure, the need for third-line ASMs, and morbidity as developmental outcome, diagnosis of cerebral palsy, and mortality rate.Results: Twenty-five patients (68% male) were recruited. Sixty-four percent were diagnosed with hypoxic ischemic encephalopathy (HIE). The most common seizure type was subtle seizure at 56%. Levetiracetam was given to 56% and phenytoin was given to 44% as second-line ASMs. The duration of seizure was significantly different at 28.12 minutes in levetiracetam and 42.72 minutes in phenytoin (p=0.01). The drug adherence was higher in the levetiracetam group. Regarding third-line ASMs, 28.7% of the levetiracetam group and 45.45% of phenytoin group needed third-line ASMs, but this was not statistically significant. Mortality was 20% and 48% were diagnosed as cerebral palsy. There was no significant difference in mortality and morbidity between the two groups.Conclusion: Levetiracetam had no superior efficacy than phenytoin in neonatal seizure.Keywords: Neonatal seizure; Levetiracetam; Phenytoin; Efficacy
背景:新生儿癫痫是一种影响神经发育和死亡率的急症。适当的治疗和癫痫的终止是至关重要的。先前的研究确定了不同类型的抗癫痫药物(asm)的疗效,但对于二线抗癫痫药物在新生儿癫痫发作中的应用尚无共识。目的:比较左乙拉西坦与苯妥英在新生儿癫痫发作中的疗效。材料与方法:本研究为回顾性研究。作者招募了2018年1月1日至2020年12月31日期间在泰国Maharat Nakhon Ratchasima医院入院的诊断为新生儿癫痫发作的患者。包括临床发作难治性患者,给予一线静脉注射苯巴比妥,并接受二线静脉注射左乙拉西坦或苯妥英等ASM。记录癫痫发作的病因、发作类型和其他人口统计学数据。左乙西坦和苯妥英的疗效是通过比较癫痫发作的持续时间、三线抗痉挛药物的需要、作为发育结局的发病率、脑瘫的诊断和死亡率来确定的。结果:招募了25例患者(68%为男性)。其中64%被诊断为缺氧缺血性脑病(HIE)。最常见的发作类型为轻微发作,占56%。左乙拉西坦占56%,苯妥英占44%。癫痫发作时间左乙拉西坦为28.12 min,苯妥英为42.72 min,两者差异有统计学意义(p=0.01)。左乙拉西坦组药物依从性较高。在三线asm方面,28.7%的左乙拉西坦组和45.45%的苯妥英组需要三线asm,但差异无统计学意义。死亡率为20%,诊断为脑瘫的占48%。两组患者的死亡率和发病率无显著差异。结论:左乙拉西坦治疗新生儿癫痫发作的疗效不优于苯妥英。关键词:新生儿癫痫发作;Levetiracetam;苯妥英;功效
{"title":"Efficacy of Levetiracetam versus Phenytoin in Neonatal Seizure in Rural Area of Thailand","authors":"","doi":"10.35755/jmedassocthai.2023.08.13877","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13877","url":null,"abstract":"Background: Neonatal seizure is an emergency condition that affects neurodevelopment and mortality. The appropriate treatment and seizure termination is crucial. Previous studies determined the efficacy of different types of antiseizure medications (ASMs), but there is no consensus toward second-line ASMs in neonatal seizure.\u0000\u0000Objective: To compare the efficacy of second-line ASMs in neonatal seizure, compared between levetiracetam and phenytoin.\u0000\u0000Materials and Methods: The present study was a retrospective study. The author recruited patients with diagnosis of neonatal seizure admitted at Maharat Nakhon Ratchasima Hospital, Thailand, between January 1, 2018 and December 31, 2020. Patients who had clinical seizure refractory and were given first-line ASM (intravenous phenobarbital) and received second-line ASMs as intravenous levetiracetam or intravenous phenytoin were included. Etiologies of seizure, seizure types, and other demographic data were recorded. The efficacy of levetiracetam and phenytoin were determined by comparing the duration of seizure, the need for third-line ASMs, and morbidity as developmental outcome, diagnosis of cerebral palsy, and mortality rate.\u0000\u0000Results: Twenty-five patients (68% male) were recruited. Sixty-four percent were diagnosed with hypoxic ischemic encephalopathy (HIE). The most common seizure type was subtle seizure at 56%. Levetiracetam was given to 56% and phenytoin was given to 44% as second-line ASMs. The duration of seizure was significantly different at 28.12 minutes in levetiracetam and 42.72 minutes in phenytoin (p=0.01). The drug adherence was higher in the levetiracetam group. Regarding third-line ASMs, 28.7% of the levetiracetam group and 45.45% of phenytoin group needed third-line ASMs, but this was not statistically significant. Mortality was 20% and 48% were diagnosed as cerebral palsy. There was no significant difference in mortality and morbidity between the two groups.\u0000\u0000Conclusion: Levetiracetam had no superior efficacy than phenytoin in neonatal seizure.\u0000\u0000Keywords: Neonatal seizure; Levetiracetam; Phenytoin; Efficacy","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80370707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameloblastoma in Siriraj Hospital: A 14-Year Retrospective Analysis of Clinicopathological Characteristics Correlating to the WHO 2017 Classification Siriraj医院成釉细胞瘤:与WHO 2017分类相关的14年临床病理特征回顾性分析
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13817
Background: Ameloblastoma is a benign, locally aggressive neoplasm eliciting frequent relapse and morbidity. Based on many updates, there is an introduction of the World Health Organization (WHO) 2017 Classification in which the terminology has been modified and re-categorized.Objective: To study natural courses, the clinicopathological characteristics, and rate of recurrence of ameloblastoma patients in Siriraj Hospital.Materials and Methods: The H&E stained slides of 122 patients diagnosed with ameloblastoma between 2006 and 2019 at Siriraj Hospital were reviewed and re-classified according to the WHO 2017 Classification. The natural course of disease and the clinicopathological characteristics were analyzed. A descriptive statistical analysis was used to calculate the frequency and percentages of different variables.Results: There were 86.9% of the cases being conventional ameloblastomas, whilst the predominant histologic pattern being the follicular pattern. The treatment of choice is excision. Recurrence of ameloblastoma is thought to be the consequence of several risk factors, clinicoradiological characteristics of the tumor, anatomical locations, treatments of choice, tumoral behavior, and tumor subtypes in particular. Thirty cases presented with recurrence, of which 83.3% were conventional ameloblastomas. Most of the cases were treated with radical treatment and have free surgical resection margins.Conclusion: The clinicopathological characteristics and natural course of ameloblastoma patients in Siriraj Hospital corresponds to the WHO Classification. The present study demonstrated a high recurrence rate in patients treated with conservative surgery. Thus, the authors agree with the WHO 2017 Classification that radical surgery is recommended for patients with a history of recurrence and some specific subtypes of ameloblastomas.Keywords: Ameloblastoma; Mandible; Neoplasm; Odontogenic tumors; Oral pathology
背景:成釉细胞瘤是一种良性的局部侵袭性肿瘤,易复发和发病。在多次更新的基础上,引入了世界卫生组织(世卫组织)2017年分类,其中对术语进行了修改和重新分类。目的:探讨诗丽拉医院成釉细胞瘤患者的自然病程、临床病理特点及复发率。材料与方法:对2006年至2019年在Siriraj医院诊断为成釉细胞瘤的122例患者的H&E染色玻片进行回顾,并根据世卫组织2017年分类进行重新分类。分析其自然病程及临床病理特征。使用描述性统计分析来计算不同变量的频率和百分比。结果:86.9%的病例为常规成釉细胞瘤,以滤泡型为主。治疗的选择是切除。成釉细胞瘤的复发被认为是几种危险因素的结果,包括肿瘤的临床放射学特征、解剖位置、治疗选择、肿瘤行为和肿瘤亚型。30例复发,其中83.3%为常规成釉细胞瘤。多数病例均行根治性治疗,并行游离切缘手术。结论:Siriraj医院成釉细胞瘤患者的临床病理特征和自然病程符合WHO分类。目前的研究表明,保守手术治疗的患者复发率很高。因此,作者同意世卫组织2017年的分类,建议对有复发史和某些特定亚型成釉细胞瘤的患者进行根治性手术。关键词:造釉细胞瘤;下颌骨;肿瘤;牙原性的肿瘤;口腔病理学
{"title":"Ameloblastoma in Siriraj Hospital: A 14-Year Retrospective Analysis of Clinicopathological Characteristics Correlating to the WHO 2017 Classification","authors":"","doi":"10.35755/jmedassocthai.2023.08.13817","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13817","url":null,"abstract":"Background: Ameloblastoma is a benign, locally aggressive neoplasm eliciting frequent relapse and morbidity. Based on many updates, there is an introduction of the World Health Organization (WHO) 2017 Classification in which the terminology has been modified and re-categorized.\u0000\u0000Objective: To study natural courses, the clinicopathological characteristics, and rate of recurrence of ameloblastoma patients in Siriraj Hospital.\u0000\u0000Materials and Methods: The H&E stained slides of 122 patients diagnosed with ameloblastoma between 2006 and 2019 at Siriraj Hospital were reviewed and re-classified according to the WHO 2017 Classification. The natural course of disease and the clinicopathological characteristics were analyzed. A descriptive statistical analysis was used to calculate the frequency and percentages of different variables.\u0000\u0000Results: There were 86.9% of the cases being conventional ameloblastomas, whilst the predominant histologic pattern being the follicular pattern. The treatment of choice is excision. Recurrence of ameloblastoma is thought to be the consequence of several risk factors, clinicoradiological characteristics of the tumor, anatomical locations, treatments of choice, tumoral behavior, and tumor subtypes in particular. Thirty cases presented with recurrence, of which 83.3% were conventional ameloblastomas. Most of the cases were treated with radical treatment and have free surgical resection margins.\u0000\u0000Conclusion: The clinicopathological characteristics and natural course of ameloblastoma patients in Siriraj Hospital corresponds to the WHO Classification. The present study demonstrated a high recurrence rate in patients treated with conservative surgery. Thus, the authors agree with the WHO 2017 Classification that radical surgery is recommended for patients with a history of recurrence and some specific subtypes of ameloblastomas.\u0000\u0000Keywords: Ameloblastoma; Mandible; Neoplasm; Odontogenic tumors; Oral pathology","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86558346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression, Generalize Anxiety Disorder, and School Avoidance in Early School Years in Pupils with Poor Reading Ability 阅读能力差学童早期抑郁、广泛性焦虑障碍与学校回避
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13880
Background: Children with poor reading ability may be at risk of early mental health problems.Objective: To determine an association between poor reading ability and generalize anxiety, school avoidance and depression among pupils in early school years.Materials and Methods: The cross-sectional study was conducted in 1,038 pupils studying in Grade 2 in 8 primary schools in Thailand. All pupils were individually assessed in their reading abilities by the Thai Standard Reading Tests. Generalized anxiety disorder and significant school avoidance were screened by using the Thai version of the Screen for Child Anxiety Related Emotional Disorders (SCARED). Depression was screened by using the Thai version of the Short Mood and Feelings Questionnaire (SMFQ).Results: A total of 877 pupils completed the tests. The mean age was 7.0 years (SD 0.4 years). The prevalence of generalized anxiety disorder, significant school avoidance, and depression were 18.4% (95% CI 15.8 to 20.9), 32.2% (95% CI 29.1 to 35.3), and 36.0% (95% CI 32.9 to 39.2), respectively. Poor reading ability was significantly associated with school avoidance with the odds ratio of 2.2 (95% CI 1.5 to 3.3, p<0.001) and depression with the odds ratio of 1.8 (95% CI 1.2 to 2.6, p=0.005), but was not significantly associated with generalized anxiety disorder.Conclusion: Poor reading ability was associated with school avoidance and depression in early school years. Emotional problems should be screened early in those with poor reading ability.Keywords: Poor reading ability; Anxiety; Depression; School avoidance; Mental health
背景:阅读能力差的儿童可能存在早期心理健康问题的风险。目的:探讨学龄期小学生阅读能力差与泛化焦虑、逃学和抑郁的关系。材料与方法:以泰国8所小学的1038名二年级学生为研究对象进行横断面研究。所有学生的阅读能力都通过泰国标准阅读测试进行了单独评估。使用泰国版儿童焦虑相关情绪障碍筛查(SCARED)对广泛性焦虑障碍和显著的学校回避进行筛查。使用泰国版的简短情绪和感觉问卷(SMFQ)筛选抑郁症。结果:共有877名学生完成了测试。平均年龄7.0岁(SD 0.4岁)。广泛性焦虑障碍、明显的逃学和抑郁的患病率分别为18.4% (95% CI 15.8至20.9)、32.2% (95% CI 29.1至35.3)和36.0% (95% CI 32.9至39.2)。阅读能力差与逃学显著相关,比值比为2.2 (95% CI 1.5 ~ 3.3, p<0.001),与抑郁显著相关,比值比为1.8 (95% CI 1.2 ~ 2.6, p=0.005),但与广泛性焦虑障碍无显著相关。结论:阅读能力差与学龄期学生逃避学校和抑郁有关。阅读能力差的孩子应该及早发现情绪问题。关键词:阅读能力差;焦虑;抑郁症;学校回避;心理健康
{"title":"Depression, Generalize Anxiety Disorder, and School Avoidance in Early School Years in Pupils with Poor Reading Ability","authors":"","doi":"10.35755/jmedassocthai.2023.08.13880","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13880","url":null,"abstract":"Background: Children with poor reading ability may be at risk of early mental health problems.\u0000\u0000Objective: To determine an association between poor reading ability and generalize anxiety, school avoidance and depression among pupils in early school years.\u0000\u0000Materials and Methods: The cross-sectional study was conducted in 1,038 pupils studying in Grade 2 in 8 primary schools in Thailand. All pupils were individually assessed in their reading abilities by the Thai Standard Reading Tests. Generalized anxiety disorder and significant school avoidance were screened by using the Thai version of the Screen for Child Anxiety Related Emotional Disorders (SCARED). Depression was screened by using the Thai version of the Short Mood and Feelings Questionnaire (SMFQ).\u0000\u0000Results: A total of 877 pupils completed the tests. The mean age was 7.0 years (SD 0.4 years). The prevalence of generalized anxiety disorder, significant school avoidance, and depression were 18.4% (95% CI 15.8 to 20.9), 32.2% (95% CI 29.1 to 35.3), and 36.0% (95% CI 32.9 to 39.2), respectively. Poor reading ability was significantly associated with school avoidance with the odds ratio of 2.2 (95% CI 1.5 to 3.3, p<0.001) and depression with the odds ratio of 1.8 (95% CI 1.2 to 2.6, p=0.005), but was not significantly associated with generalized anxiety disorder.\u0000\u0000Conclusion: Poor reading ability was associated with school avoidance and depression in early school years. Emotional problems should be screened early in those with poor reading ability.\u0000\u0000Keywords: Poor reading ability; Anxiety; Depression; School avoidance; Mental health","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88108959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Choice of Anesthesia after First Failed Spinal Block and Its Impact on Maternal and Neonatal Outcomes in Cesarean Delivery: A Cross-Sectional Study 剖宫产首次脊髓阻滞失败后麻醉的选择及其对产妇和新生儿结局的影响:一项横断面研究
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13875
Objective: The preferred choice of anesthesia for cesarean delivery is spinal block, which has a failure rate of 0.5% to 17.0%. The present study investigated the incident rate of second choice of anesthesia following a failed block, as well as the factors influencing the anesthesiologist’s selection.Materials and Methods: A single-center, retrospective cross-sectional study was conducted using electronic medical records of parturients who had experienced a failed spinal block for cesarean deliveries between 2014 and 2019. Each rate of repeated spinal block and the conversion to general anesthesia were calculated. Factors associated with the decision-making were examined, and maternal and neonatal outcomes were reviewed.Results: Three hundred four women were recruited. The rates of repeated block and conversion to general anesthesia were 81.2% and 18.8%, respectively. Dural puncture with more than one attempt (p=0.022) and anesthesia level at the thoracic dermatome (p<0.001) were associated with a lower decision to repeat the block. Maternal in the repeated block group had a higher incidence of hypotension at 59.5% (p<0.001) and shivering at 16.2% (p=0.008). Neonates in the repeat block group had a lower incidence of any complications than those in the conversion to general anesthesia group at 4% versus 29.8% (p<0.001).Conclusion: Following an unsuccessful spinal block for cesarean section, the repeated block was still preferred. The level of anesthesia and the spinal attempts were the significant factors in this choice.Keywords: Cesarean delivery; Conversion to general anesthesia; Failed spinal block; Maternal and neonatal outcomes; Repeat block
目的:剖宫产术首选麻醉方式为脊髓阻滞,其失败率为0.5% ~ 17.0%。本研究调查了阻滞失败后再次选择麻醉的发生率,以及影响麻醉医师选择的因素。材料与方法:利用2014年至2019年剖宫产脊柱阻滞失败的产妇电子病历进行单中心、回顾性横断面研究。计算每次脊髓阻滞重复率及转全麻率。研究了与决策相关的因素,并审查了孕产妇和新生儿的结局。结果:共招募了340名女性。重复阻滞率为81.2%,转全麻率为18.8%。多次尝试硬脑膜穿刺(p=0.022)和胸皮段麻醉水平(p<0.001)与较低的重复阻滞决定相关。重复阻滞组产妇低血压发生率为59.5% (p<0.001),寒战发生率为16.2% (p=0.008)。重复阻滞组新生儿的并发症发生率低于全麻组,分别为4%和29.8% (p<0.001)。结论:剖宫产术脊柱阻滞失败后,仍可选择重复阻滞。麻醉水平和脊柱尝试是这一选择的重要因素。关键词:剖宫产;转为全身麻醉;脊髓阻滞失败;孕产妇和新生儿结局;重复块
{"title":"The Choice of Anesthesia after First Failed Spinal Block and Its Impact on Maternal and Neonatal Outcomes in Cesarean Delivery: A Cross-Sectional Study","authors":"","doi":"10.35755/jmedassocthai.2023.08.13875","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13875","url":null,"abstract":"Objective: The preferred choice of anesthesia for cesarean delivery is spinal block, which has a failure rate of 0.5% to 17.0%. The present study investigated the incident rate of second choice of anesthesia following a failed block, as well as the factors influencing the anesthesiologist’s selection.\u0000\u0000Materials and Methods: A single-center, retrospective cross-sectional study was conducted using electronic medical records of parturients who had experienced a failed spinal block for cesarean deliveries between 2014 and 2019. Each rate of repeated spinal block and the conversion to general anesthesia were calculated. Factors associated with the decision-making were examined, and maternal and neonatal outcomes were reviewed.\u0000\u0000Results: Three hundred four women were recruited. The rates of repeated block and conversion to general anesthesia were 81.2% and 18.8%, respectively. Dural puncture with more than one attempt (p=0.022) and anesthesia level at the thoracic dermatome (p<0.001) were associated with a lower decision to repeat the block. Maternal in the repeated block group had a higher incidence of hypotension at 59.5% (p<0.001) and shivering at 16.2% (p=0.008). Neonates in the repeat block group had a lower incidence of any complications than those in the conversion to general anesthesia group at 4% versus 29.8% (p<0.001).\u0000\u0000Conclusion: Following an unsuccessful spinal block for cesarean section, the repeated block was still preferred. The level of anesthesia and the spinal attempts were the significant factors in this choice.\u0000\u0000Keywords: Cesarean delivery; Conversion to general anesthesia; Failed spinal block; Maternal and neonatal outcomes; Repeat block","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79010189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthy Ageing and Associated Factors among the Older Adults Living in Government Social Welfare Home for Older Persons in Southern Thailand: An Analytical Cross-Sectional Study 泰国南部政府社会福利院老年人的健康老龄化及其相关因素:一项分析性横断面研究
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13865
Background: Institutionalized older adults tend to experience higher levels of impaired health conditions compared to older persons living in the community. Healthy ageing is a global objective, however, there is limited knowledge about promoting healthy ageing specifically among older persons in social welfare homes.Objective: To examine the prevalence and factors associated with healthy ageing among institutionalized older adults in government social welfare home for older persons (GSWHOP) in the complex societies of the Southern region of Thailand.Materials and Methods: The present study was an analytical cross-sectional study that included 126 older participants aged 60 years or older capable of self-help activities. The present study defined healthy ageing as having independent physical function, good mental health status with no depression, normal nutrition status, and good quality of life.Results: Approximately 33.3% of the older residents who were capable of self-help activities achieved healthy ageing. There was no significant difference in the prevalence of healthy ageing between men at 36.2% and women at 30.9% (p>0.05). After controlling for other covariates, the present study found that factors such as length of institutional stay, knowledge of health promotion behavior (HPB), perceived stress, received HPB related information, and exercise were significantly associated with healthy ageing (p<0.05 to p<0.001).Conclusion: The present study revealed that approximately one in three institutionalized older residents in southern Thailand met the criteria for healthy ageing. The findings indicate the importance of social welfare staff, administrators, and policymakers in implementing effective solutions. These include providing practical knowledge of HPBs, promoting regular exercise, and implementing stress management strategies for institutionalized older adults. Targeting individuals after their first year of institutional stay is crucial. These measures can improve the health and well-being of institutionalized older adults in the region.Keywords: Healthy ageing; Institutionalized older adults; Health promotion behaviors; Educational and ecological factors; Quality of life; Southern Thailand
背景:与生活在社区的老年人相比,住在机构中的老年人往往经历更高程度的健康状况受损。健康老龄化是一个全球目标,然而,在促进健康老龄化方面的知识有限,特别是在社会福利院的老年人中。目的:探讨泰国南部地区复杂社会中政府老年人社会福利院(GSWHOP)机构老年人健康老龄化的患病率及其相关因素。材料和方法:本研究是一项分析性横断面研究,包括126名60岁及以上有自助能力的老年人。本研究将健康老龄化定义为具有独立的身体功能,良好的心理健康状态,无抑郁,正常的营养状况和良好的生活质量。结果:有自理能力的老年人达到健康老龄化的比例约为33.3%。健康老龄化患病率男性为36.2%,女性为30.9%,差异无统计学意义(p < 0.05)。在控制其他协变量后,本研究发现住院时间、健康促进行为(HPB)知识、感知压力、接受健康促进行为相关信息和运动等因素与健康老龄化显著相关(p<0.05 ~ p<0.001)。结论:目前的研究表明,泰国南部大约三分之一的机构老年居民符合健康老龄化的标准。研究结果表明,社会福利工作人员、管理人员和政策制定者在实施有效解决方案方面的重要性。这些措施包括提供HPBs的实用知识,促进有规律的锻炼,以及为养老院的老年人实施压力管理策略。针对那些在机构待了一年后的人是至关重要的。这些措施可以改善该地区被机构收容的老年人的健康和福祉。关键词:健康老龄化;被收容的老年人;健康促进行为;教育和生态因素;生活质量;泰国南部
{"title":"Healthy Ageing and Associated Factors among the Older Adults Living in Government Social Welfare Home for Older Persons in Southern Thailand: An Analytical Cross-Sectional Study","authors":"","doi":"10.35755/jmedassocthai.2023.08.13865","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13865","url":null,"abstract":"Background: Institutionalized older adults tend to experience higher levels of impaired health conditions compared to older persons living in the community. Healthy ageing is a global objective, however, there is limited knowledge about promoting healthy ageing specifically among older persons in social welfare homes.\u0000\u0000Objective: To examine the prevalence and factors associated with healthy ageing among institutionalized older adults in government social welfare home for older persons (GSWHOP) in the complex societies of the Southern region of Thailand.\u0000\u0000Materials and Methods: The present study was an analytical cross-sectional study that included 126 older participants aged 60 years or older capable of self-help activities. The present study defined healthy ageing as having independent physical function, good mental health status with no depression, normal nutrition status, and good quality of life.\u0000\u0000Results: Approximately 33.3% of the older residents who were capable of self-help activities achieved healthy ageing. There was no significant difference in the prevalence of healthy ageing between men at 36.2% and women at 30.9% (p>0.05). After controlling for other covariates, the present study found that factors such as length of institutional stay, knowledge of health promotion behavior (HPB), perceived stress, received HPB related information, and exercise were significantly associated with healthy ageing (p<0.05 to p<0.001).\u0000\u0000Conclusion: The present study revealed that approximately one in three institutionalized older residents in southern Thailand met the criteria for healthy ageing. The findings indicate the importance of social welfare staff, administrators, and policymakers in implementing effective solutions. These include providing practical knowledge of HPBs, promoting regular exercise, and implementing stress management strategies for institutionalized older adults. Targeting individuals after their first year of institutional stay is crucial. These measures can improve the health and well-being of institutionalized older adults in the region.\u0000\u0000Keywords: Healthy ageing; Institutionalized older adults; Health promotion behaviors; Educational and ecological factors; Quality of life; Southern Thailand","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86255348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and Adverse Events of Generic and Original Imipenem/Cilastatin in Hospitalized Patients: The First Multicenter Non-Inferiority Study in Thailand 泰国首个多中心非劣效性研究:亚胺培南/西司他汀在住院患者中的有效性和不良事件
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13876
Objective: Imipenem/cilastatin, a broad-spectrum antibacterial, is reserved for treatment of serious infections caused by multidrug-resistant Gram-negative bacteria. The present study was aimed to compare the effectiveness and adverse events of generic and original imipenem/cilastatin.Materials and Methods:A retrospective, multicenter, cohort, non-inferiority study of generic imipenem/cilastatin (Sianem®), and original imipenem/cilastatin (Tienam®) was carried on between November 2017 and September 2020. The centers included Srinagarind Hospital, Taksin Hospital, Nakornping Hospital, Nakhonpathom Hospital, and King Chulalongkorn Memorial Hospital. The clinically relevant data were retrieved from the medical records on day 3, 7, and 14 after enrollment. A sample size of 260 patients per arm was needed.Results: There were 214 and 227 medical and surgical patients enrolled in generic and original imipenem/cilastatin groups, respectively. Baseline characteristics of the two groups were not significantly different. Most patients were male and elderly. Comorbidity was observed in 86.6%. The average length of hospital stay was 17 days. At day 14 after enrollment, the favorable outcome in generic and original imipenem/cilastatin groups were 83.1% and 90.0%, respectively, with no statistical difference. The mortality rates were 3.4% and 2.0% in generic and original imipenem/ cilastatin groups, respectively, with no statistic difference. Serious adverse events were also not significantly different between the two groups at 0.9% and 0.4%.Conclusion: The generic imipenem/cilastatin was non-inferior to the original imipenem/cilastatin in terms of effectiveness and adverse events for the treatment of serious bacterial infections in hospitalized adult patients.Keywords: Effectiveness; Safety; Adverse events; Generic drug; Imipenem/cilastatin
目的:亚胺培南/西司他汀是一种广谱抗菌药物,用于治疗多重耐药革兰氏阴性菌引起的严重感染。本研究旨在比较仿制药和原厂亚胺培南/西司他汀的疗效和不良事件。材料与方法:2017年11月至2020年9月,对仿制亚胺培南/西司他汀(Sianem®)和原亚胺培南/西司他汀(Tienam®)进行回顾性、多中心、队列、非劣效性研究。这些中心包括斯利那加林德医院、他信医院、Nakornping医院、Nakhonpathom医院和朱拉隆功国王纪念医院。在入组后第3、7、14天从病历中检索临床相关数据。每组需要260例患者的样本量。结果:非专利组和原亚胺培南/西司他汀组分别纳入214例和227例内科和外科患者。两组患者的基线特征无显著差异。患者多为男性和老年人。共病发生率为86.6%。平均住院时间为17天。入组后第14天,亚胺培南/西司他汀仿制组和原亚胺培南/西司他汀组的良好预后分别为83.1%和90.0%,差异无统计学意义。仿制组和原亚胺培南/西司他汀组的死亡率分别为3.4%和2.0%,差异无统计学意义。两组的严重不良事件发生率也无显著差异,分别为0.9%和0.4%。结论:亚胺培南/西司他汀仿制药治疗成人住院重症细菌感染的疗效和不良事件均不低于原亚胺培南/西司他汀。关键词:有效性;安全;不良事件;仿制药;Imipenem / cilastatin
{"title":"Effectiveness and Adverse Events of Generic and Original Imipenem/Cilastatin in Hospitalized Patients: The First Multicenter Non-Inferiority Study in Thailand","authors":"","doi":"10.35755/jmedassocthai.2023.08.13876","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13876","url":null,"abstract":"Objective: Imipenem/cilastatin, a broad-spectrum antibacterial, is reserved for treatment of serious infections caused by multidrug-resistant Gram-negative bacteria. The present study was aimed to compare the effectiveness and adverse events of generic and original imipenem/cilastatin.\u0000\u0000Materials and Methods:A retrospective, multicenter, cohort, non-inferiority study of generic imipenem/cilastatin (Sianem®), and original imipenem/cilastatin (Tienam®) was carried on between November 2017 and September 2020. The centers included Srinagarind Hospital, Taksin Hospital, Nakornping Hospital, Nakhonpathom Hospital, and King Chulalongkorn Memorial Hospital. The clinically relevant data were retrieved from the medical records on day 3, 7, and 14 after enrollment. A sample size of 260 patients per arm was needed.\u0000\u0000Results: There were 214 and 227 medical and surgical patients enrolled in generic and original imipenem/cilastatin groups, respectively. Baseline characteristics of the two groups were not significantly different. Most patients were male and elderly. Comorbidity was observed in 86.6%. The average length of hospital stay was 17 days. At day 14 after enrollment, the favorable outcome in generic and original imipenem/cilastatin groups were 83.1% and 90.0%, respectively, with no statistical difference. The mortality rates were 3.4% and 2.0% in generic and original imipenem/ cilastatin groups, respectively, with no statistic difference. Serious adverse events were also not significantly different between the two groups at 0.9% and 0.4%.\u0000\u0000Conclusion: The generic imipenem/cilastatin was non-inferior to the original imipenem/cilastatin in terms of effectiveness and adverse events for the treatment of serious bacterial infections in hospitalized adult patients.\u0000\u0000Keywords: Effectiveness; Safety; Adverse events; Generic drug; Imipenem/cilastatin","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85981842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Prehospital Factors for Predicting Massive Blood Transfusion in Trauma Patients 预测创伤患者大量输血的院前因素研究进展
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13874
Background: Massive blood loss is the primary cause of immediate death in trauma patients. In prehospital care, where laboratory and investigation resources are limited, a massive blood transfusion (MBT) scoring system could activate blood bank preparation of blood components and facilitate EMS decision-making regarding the appropriate trauma center destination. This is particularly significant in urban environments where motor vehicle accidents are highly prevalent.Materials and Methods: A retrospective cohort study was conducted using data from prehospital trauma patients. Predictive parameters, including vital signs, mechanism of injury, and serious injury body parts, were analyzed, and the significant parameters identified by a multivariable analysis were used to develop a clinical scoring system. Discrimination was evaluated by the area under the receiver operating characteristic (AuROC) curve, calibration was demonstrated with the Hosmer-Lemeshow goodness of fit test, and internal validation was performed.Results: Among 511 trauma patients, 72 (14.1%) received MBT. The prehospital factors that significantly predicted massive MBT included hypotension with a SBP of less than 90 mmHg, penetrating object injuries, serious injuries to the face, thorax, abdomen, extremities including the pelvis, and the use of life-saving interventions such as advanced airway management and pelvic binding. The AuROC was 0.943 (95% CI 0.914 to 0.972, p<0.001). The probability of receiving massive transfusion was 94.79% in patients with score of 5 or higher.Conclusion: The prehospital MBT score demonstrates good performance and discrimination for predicting MBT using simple and rapidly obtainable parameters in a prehospital setting.Keywords: Massive transfusion; Massive bleeding; Prehospital care
背景:大量失血是创伤患者立即死亡的主要原因。在实验室和调查资源有限的院前护理中,大规模输血(MBT)评分系统可以激活血库准备血液成分,促进EMS对合适的创伤中心目的地的决策。这在机动车事故非常普遍的城市环境中尤为重要。材料和方法:采用院前创伤患者的资料进行回顾性队列研究。对生命体征、损伤机制、严重损伤部位等预测参数进行分析,并通过多变量分析识别出显著性参数,建立临床评分系统。采用受试者工作特征曲线下面积(AuROC)评价鉴别性,采用Hosmer-Lemeshow拟合优度检验进行标定,并进行内部验证。结果:511例外伤患者中,72例(14.1%)接受了MBT治疗。院前因素可显著预测大面积MBT,包括收缩压低于90 mmHg的低血压、穿透性物体损伤、面部、胸部、腹部、四肢(包括骨盆)的严重损伤,以及使用挽救生命的干预措施,如先进的气道管理和骨盆捆绑。AuROC为0.943 (95% CI 0.914 ~ 0.972, p<0.001)。5分及以上患者接受大量输血的概率为94.79%。结论:院前MBT评分在预测院前MBT方面具有良好的性能和判别性,使用简单、快速获得的参数。关键词:大量输血;大量出血;院前护理
{"title":"Development of Prehospital Factors for Predicting Massive Blood Transfusion in Trauma Patients","authors":"","doi":"10.35755/jmedassocthai.2023.08.13874","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13874","url":null,"abstract":"Background: Massive blood loss is the primary cause of immediate death in trauma patients. In prehospital care, where laboratory and investigation resources are limited, a massive blood transfusion (MBT) scoring system could activate blood bank preparation of blood components and facilitate EMS decision-making regarding the appropriate trauma center destination. This is particularly significant in urban environments where motor vehicle accidents are highly prevalent.\u0000\u0000Materials and Methods: A retrospective cohort study was conducted using data from prehospital trauma patients. Predictive parameters, including vital signs, mechanism of injury, and serious injury body parts, were analyzed, and the significant parameters identified by a multivariable analysis were used to develop a clinical scoring system. Discrimination was evaluated by the area under the receiver operating characteristic (AuROC) curve, calibration was demonstrated with the Hosmer-Lemeshow goodness of fit test, and internal validation was performed.\u0000\u0000Results: Among 511 trauma patients, 72 (14.1%) received MBT. The prehospital factors that significantly predicted massive MBT included hypotension with a SBP of less than 90 mmHg, penetrating object injuries, serious injuries to the face, thorax, abdomen, extremities including the pelvis, and the use of life-saving interventions such as advanced airway management and pelvic binding. The AuROC was 0.943 (95% CI 0.914 to 0.972, p<0.001). The probability of receiving massive transfusion was 94.79% in patients with score of 5 or higher.\u0000\u0000Conclusion: The prehospital MBT score demonstrates good performance and discrimination for predicting MBT using simple and rapidly obtainable parameters in a prehospital setting.\u0000\u0000Keywords: Massive transfusion; Massive bleeding; Prehospital care","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83435044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Incidence of Ischemic Stroke in Cancer Patients in Thailand 泰国癌症患者缺血性脑卒中的发病率
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13873
Objective: Cancer and stroke are leading causes of morbidity and mortality in Thailand. The objectives of the present study were 1) to determine the incidence of ischemic stroke in cancer patients in Thailand, 2) to identify the cancer subtypes most associated with ischemic stroke, and 3) to compare the etiology of stroke in two groups of patients, those who had conventional risk factors for stroke and those without conventional risk factors or cryptogenic stroke.Materials and Methods: The present study was a retrospective descriptive study. The authors collected data on cancer patients hospitalized between 2008 and 2020 according to International Classification of Disease and Related Health Problem Tenth Revision (ICD-10) and identified the number of ischemic stroke patients and the cancer subtype for each patient. Risk factors for stroke were identified as conventional risk factors (hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, smoking, and imaging evidence of atherosclerosis) and cryptogenic risk factors (none of the conventional risk factors).Results: Sixteen thousand six hundred forty-seven cancer patients were included in the present study and 85 of these patients were diagnosed with ischemic stroke. Therefore, the incidence of ischemic stroke in cancer patients was 0.51%. The cancer subtypes most often associated with ischemic stroke were thoracic as predominantly lung, lower gastrointestinal tract, and hepatobiliary cancer. Most patients (88.24%) had at least one conventional risk factor. Hypertension was the most common conventional risk factor. Cryptogenic stroke was found in 5.88% of the patients and 5.88% of the patients had insufficient data on risk factors.Conclusion: The incidence of ischemic stroke in Thai cancer patients is low. Lung cancer is the cancer type most associated with ischemic stroke. Most cancer patients with ischemic stroke had multiple vascular risk factors.Keywords: Stroke; Cancer; Incidence
目的:癌症和中风是泰国发病率和死亡率的主要原因。本研究的目的是1)确定泰国癌症患者缺血性卒中的发病率,2)确定与缺血性卒中最相关的癌症亚型,3)比较两组患者的卒中病因,两组患者有常规卒中危险因素和没有常规卒中危险因素或隐源性卒中。材料与方法:本研究为回顾性描述性研究。作者根据国际疾病和相关健康问题分类第十版(ICD-10)收集了2008年至2020年间住院的癌症患者的数据,并确定了每位患者的缺血性卒中患者数量和癌症亚型。卒中的危险因素被确定为常规危险因素(高血压、糖尿病、血脂异常、心房颤动、吸烟和动脉粥样硬化的影像学证据)和隐源性危险因素(没有常规危险因素)。结果:本研究共纳入16647例癌症患者,其中85例诊断为缺血性脑卒中。因此,肿瘤患者缺血性脑卒中的发生率为0.51%。与缺血性脑卒中最相关的癌症亚型是胸腔癌(以肺癌为主)、下胃肠道癌和肝胆癌。大多数患者(88.24%)至少存在一种常规危险因素。高血压是最常见的常规危险因素。5.88%的患者存在隐源性卒中,5.88%的患者危险因素资料不足。结论:泰国肿瘤患者缺血性脑卒中发生率较低。肺癌是与缺血性中风最相关的癌症类型。大多数癌症合并缺血性脑卒中患者存在多种血管危险因素。关键词:中风;癌症;发病率
{"title":"The Incidence of Ischemic Stroke in Cancer Patients in Thailand","authors":"","doi":"10.35755/jmedassocthai.2023.08.13873","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13873","url":null,"abstract":"Objective: Cancer and stroke are leading causes of morbidity and mortality in Thailand. The objectives of the present study were 1) to determine the incidence of ischemic stroke in cancer patients in Thailand, 2) to identify the cancer subtypes most associated with ischemic stroke, and 3) to compare the etiology of stroke in two groups of patients, those who had conventional risk factors for stroke and those without conventional risk factors or cryptogenic stroke.\u0000\u0000Materials and Methods: The present study was a retrospective descriptive study. The authors collected data on cancer patients hospitalized between 2008 and 2020 according to International Classification of Disease and Related Health Problem Tenth Revision (ICD-10) and identified the number of ischemic stroke patients and the cancer subtype for each patient. Risk factors for stroke were identified as conventional risk factors (hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, smoking, and imaging evidence of atherosclerosis) and cryptogenic risk factors (none of the conventional risk factors).\u0000\u0000Results: Sixteen thousand six hundred forty-seven cancer patients were included in the present study and 85 of these patients were diagnosed with ischemic stroke. Therefore, the incidence of ischemic stroke in cancer patients was 0.51%. The cancer subtypes most often associated with ischemic stroke were thoracic as predominantly lung, lower gastrointestinal tract, and hepatobiliary cancer. Most patients (88.24%) had at least one conventional risk factor. Hypertension was the most common conventional risk factor. Cryptogenic stroke was found in 5.88% of the patients and 5.88% of the patients had insufficient data on risk factors.\u0000\u0000Conclusion: The incidence of ischemic stroke in Thai cancer patients is low. Lung cancer is the cancer type most associated with ischemic stroke. Most cancer patients with ischemic stroke had multiple vascular risk factors.\u0000\u0000Keywords: Stroke; Cancer; Incidence","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85107123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioral Risk Score for Predicting Well-Controlled HbA1c Level in Diabetes Type 2 Patients 预测2型糖尿病患者控制良好的HbA1c水平的行为风险评分
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.35755/jmedassocthai.2023.08.13881
Background: Diabetes Type 2 is chronic disease that can progress from simple hyperglycemia to severe complications. Many behavioral risks have been discovered for blood sugar prediction.Objective: To develop a simple behavioral risk scoring to predict well-controlled HbA1c level in diabetes type 2 patients.Materials and Methods: A total of 140 diabetes type 2 patients were recruited. Patients were interviewed about behavioral factors affecting blood sugar in three months retrospectively. To develop the risk score, risk indicators measured at the time of recruitment were built by logistic regression. Regression coefficients were transformed into item scores and added up to a total score. A risk scoring scheme was developed from behavioral predictors: eating desserts and soft drinks, regular exercise and strict medication intake. The scoring scheme was applied in bootstrap internal validity test to test the model performance.Results: The scheme explained, by area under the receiver operating characteristic curve (AuROC), 91.6% (95% CI 0.87 to 0.96) of being good diabetic control (HbA1c ≤7%) with good calibration (Hosmer-Lemeshow χ²=3.61; p=0.61). The likelihood ratio of being good diabetic control (scores greater than or equal to 1) and poor diabetic control (score lower than 1) were 3.83 (95% CI 2.69 to 5.46) and 0.11 (95% CI 0.05 to 0.21), respectively. When applied in bootstrap internal validity test, the score showed good performance with AuROC 88.7% (95% CI 0.81 to 0.93).Conclusion: A simple and non-invasive scoring scheme of three predictors provides good prediction indices for being good and poor diabetic control patients. This scheme may help clinicians in order to take further appropriate action for diabetic control.Keywords: Diabetes type 2; HbA1c controlling level; Prediction; Risk scoring
背景:2型糖尿病是一种慢性疾病,可以从单纯的高血糖发展到严重的并发症。许多行为风险已被发现用于预测血糖。目的:建立一种简单的行为风险评分方法来预测2型糖尿病患者控制良好的HbA1c水平。材料与方法:共招募140例2型糖尿病患者。回顾性随访3个月,了解影响血糖的行为因素。为编制风险评分,采用logistic回归方法构建招聘时测量的风险指标。回归系数被转换成项目得分,并加起来成为总分。根据行为预测因素制定了风险评分方案:吃甜点和软饮料,定期锻炼和严格的药物摄入。将该计分方案应用于bootstrap内部效度检验,检验模型的性能。结果:通过受试者工作特征曲线下面积(AuROC),该方案解释了91.6% (95% CI 0.87 ~ 0.96)的糖尿病控制良好(HbA1c≤7%),校准良好(Hosmer-Lemeshow χ²=3.61;p = 0.61)。糖尿病控制良好(评分≥1)和糖尿病控制不良(评分低于1)的似然比分别为3.83 (95% CI 2.69 ~ 5.46)和0.11 (95% CI 0.05 ~ 0.21)。应用bootstrap内部效度检验时,得分的AuROC为88.7% (95% CI 0.81 ~ 0.93)。结论:简单、无创的三种预测指标评分方案为糖尿病控制好坏患者提供了较好的预测指标。该方案可以帮助临床医生采取进一步适当的措施来控制糖尿病。关键词:2型糖尿病;HbA1c控制水平;预测;风险评分
{"title":"Behavioral Risk Score for Predicting Well-Controlled HbA1c Level in Diabetes Type 2 Patients","authors":"","doi":"10.35755/jmedassocthai.2023.08.13881","DOIUrl":"https://doi.org/10.35755/jmedassocthai.2023.08.13881","url":null,"abstract":"Background: Diabetes Type 2 is chronic disease that can progress from simple hyperglycemia to severe complications. Many behavioral risks have been discovered for blood sugar prediction.\u0000\u0000Objective: To develop a simple behavioral risk scoring to predict well-controlled HbA1c level in diabetes type 2 patients.\u0000\u0000Materials and Methods: A total of 140 diabetes type 2 patients were recruited. Patients were interviewed about behavioral factors affecting blood sugar in three months retrospectively. To develop the risk score, risk indicators measured at the time of recruitment were built by logistic regression. Regression coefficients were transformed into item scores and added up to a total score. A risk scoring scheme was developed from behavioral predictors: eating desserts and soft drinks, regular exercise and strict medication intake. The scoring scheme was applied in bootstrap internal validity test to test the model performance.\u0000\u0000Results: The scheme explained, by area under the receiver operating characteristic curve (AuROC), 91.6% (95% CI 0.87 to 0.96) of being good diabetic control (HbA1c ≤7%) with good calibration (Hosmer-Lemeshow χ²=3.61; p=0.61). The likelihood ratio of being good diabetic control (scores greater than or equal to 1) and poor diabetic control (score lower than 1) were 3.83 (95% CI 2.69 to 5.46) and 0.11 (95% CI 0.05 to 0.21), respectively. When applied in bootstrap internal validity test, the score showed good performance with AuROC 88.7% (95% CI 0.81 to 0.93).\u0000\u0000Conclusion: A simple and non-invasive scoring scheme of three predictors provides good prediction indices for being good and poor diabetic control patients. This scheme may help clinicians in order to take further appropriate action for diabetic control.\u0000\u0000Keywords: Diabetes type 2; HbA1c controlling level; Prediction; Risk scoring","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78480752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Medical Association of Thailand = Chotmaihet thangphaet
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1